
Exosome molecular detection refers to methods and technologies used to identify, isolate, and analyze exosomes at the molecular level.
The global Exosome Rapid Molecular Detection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
publisher' newest research report, the “Exosome Rapid Molecular Detection Industry Forecast” looks at past sales and reviews total world Exosome Rapid Molecular Detection sales in 2023, providing a comprehensive analysis by region and market sector of projected Exosome Rapid Molecular Detection sales for 2024 through 2030. With Exosome Rapid Molecular Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Rapid Molecular Detection industry.
This Insight Report provides a comprehensive analysis of the global Exosome Rapid Molecular Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Exosome Rapid Molecular Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Rapid Molecular Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Rapid Molecular Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Rapid Molecular Detection.
United States market for Exosome Rapid Molecular Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Rapid Molecular Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Rapid Molecular Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Rapid Molecular Detection players cover Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN and Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Rapid Molecular Detection market by product type, application, key players and key regions and countries.
Segmentation by type
Kits & Reagents
Instruments
Services
Segmentation by application
Cancers
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Bio-Techne
System Biosciences
QIAGEN
Lonza
NX Pharmagen
NanoSomiX
Miltenyi Biotech
Norgen Biotek
AMSBio
Aethlon Medical
Anjarium Biosciences
Ciloa
InnovaPrep
Creative Medical Technologies
ILIAS Biologics
Unchained Labs
Rion
Cell Guidance System
INOVIQ
Danaher
Exopharm
Everzom
RoosterBio
Creative Biolabs
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exosome Rapid Molecular Detection Market Size 2019-2030
2.1.2 Exosome Rapid Molecular Detection Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Exosome Rapid Molecular Detection Segment by Type
2.2.1 Kits & Reagents
2.2.2 Instruments
2.2.3 Services
2.3 Exosome Rapid Molecular Detection Market Size by Type
2.3.1 Exosome Rapid Molecular Detection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Rapid Molecular Detection Market Size Market Share by Type (2019-2024)
2.4 Exosome Rapid Molecular Detection Segment by Application
2.4.1 Cancers
2.4.2 Neurodegenerative Diseases
2.4.3 Cardiovascular Diseases
2.4.4 Infectious Diseases
2.4.5 Other
2.5 Exosome Rapid Molecular Detection Market Size by Application
2.5.1 Exosome Rapid Molecular Detection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Rapid Molecular Detection Market Size Market Share by Application (2019-2024)
3 Exosome Rapid Molecular Detection Market Size by Player
3.1 Exosome Rapid Molecular Detection Market Size Market Share by Players
3.1.1 Global Exosome Rapid Molecular Detection Revenue by Players (2019-2024)
3.1.2 Global Exosome Rapid Molecular Detection Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Rapid Molecular Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Rapid Molecular Detection by Regions
4.1 Exosome Rapid Molecular Detection Market Size by Regions (2019-2024)
4.2 Americas Exosome Rapid Molecular Detection Market Size Growth (2019-2024)
4.3 APAC Exosome Rapid Molecular Detection Market Size Growth (2019-2024)
4.4 Europe Exosome Rapid Molecular Detection Market Size Growth (2019-2024)
4.5 Middle East & Africa Exosome Rapid Molecular Detection Market Size Growth (2019-2024)
5 Americas
5.1 Americas Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
5.2 Americas Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
5.3 Americas Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Rapid Molecular Detection Market Size by Region (2019-2024)
6.2 APAC Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
6.3 APAC Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Rapid Molecular Detection by Country (2019-2024)
7.2 Europe Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
7.3 Europe Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Rapid Molecular Detection by Region (2019-2024)
8.2 Middle East & Africa Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Exosome Rapid Molecular Detection Market Forecast
10.1 Global Exosome Rapid Molecular Detection Forecast by Regions (2025-2030)
10.1.1 Global Exosome Rapid Molecular Detection Forecast by Regions (2025-2030)
10.1.2 Americas Exosome Rapid Molecular Detection Forecast
10.1.3 APAC Exosome Rapid Molecular Detection Forecast
10.1.4 Europe Exosome Rapid Molecular Detection Forecast
10.1.5 Middle East & Africa Exosome Rapid Molecular Detection Forecast
10.2 Americas Exosome Rapid Molecular Detection Forecast by Country (2025-2030)
10.2.1 United States Exosome Rapid Molecular Detection Market Forecast
10.2.2 Canada Exosome Rapid Molecular Detection Market Forecast
10.2.3 Mexico Exosome Rapid Molecular Detection Market Forecast
10.2.4 Brazil Exosome Rapid Molecular Detection Market Forecast
10.3 APAC Exosome Rapid Molecular Detection Forecast by Region (2025-2030)
10.3.1 China Exosome Rapid Molecular Detection Market Forecast
10.3.2 Japan Exosome Rapid Molecular Detection Market Forecast
10.3.3 Korea Exosome Rapid Molecular Detection Market Forecast
10.3.4 Southeast Asia Exosome Rapid Molecular Detection Market Forecast
10.3.5 India Exosome Rapid Molecular Detection Market Forecast
10.3.6 Australia Exosome Rapid Molecular Detection Market Forecast
10.4 Europe Exosome Rapid Molecular Detection Forecast by Country (2025-2030)
10.4.1 Germany Exosome Rapid Molecular Detection Market Forecast
10.4.2 France Exosome Rapid Molecular Detection Market Forecast
10.4.3 UK Exosome Rapid Molecular Detection Market Forecast
10.4.4 Italy Exosome Rapid Molecular Detection Market Forecast
10.4.5 Russia Exosome Rapid Molecular Detection Market Forecast
10.5 Middle East & Africa Exosome Rapid Molecular Detection Forecast by Region (2025-2030)
10.5.1 Egypt Exosome Rapid Molecular Detection Market Forecast
10.5.2 South Africa Exosome Rapid Molecular Detection Market Forecast
10.5.3 Israel Exosome Rapid Molecular Detection Market Forecast
10.5.4 Turkey Exosome Rapid Molecular Detection Market Forecast
10.5.5 GCC Countries Exosome Rapid Molecular Detection Market Forecast
10.6 Global Exosome Rapid Molecular Detection Forecast by Type (2025-2030)
10.7 Global Exosome Rapid Molecular Detection Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Exosome Rapid Molecular Detection Product Offered
11.1.3 Thermo Fisher Scientific Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Exosome Rapid Molecular Detection Product Offered
11.2.3 Bio-Techne Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 System Biosciences
11.3.1 System Biosciences Company Information
11.3.2 System Biosciences Exosome Rapid Molecular Detection Product Offered
11.3.3 System Biosciences Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 System Biosciences Main Business Overview
11.3.5 System Biosciences Latest Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Information
11.4.2 QIAGEN Exosome Rapid Molecular Detection Product Offered
11.4.3 QIAGEN Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 QIAGEN Main Business Overview
11.4.5 QIAGEN Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Exosome Rapid Molecular Detection Product Offered
11.5.3 Lonza Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 NX Pharmagen
11.6.1 NX Pharmagen Company Information
11.6.2 NX Pharmagen Exosome Rapid Molecular Detection Product Offered
11.6.3 NX Pharmagen Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 NX Pharmagen Main Business Overview
11.6.5 NX Pharmagen Latest Developments
11.7 NanoSomiX
11.7.1 NanoSomiX Company Information
11.7.2 NanoSomiX Exosome Rapid Molecular Detection Product Offered
11.7.3 NanoSomiX Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NanoSomiX Main Business Overview
11.7.5 NanoSomiX Latest Developments
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Information
11.8.2 Miltenyi Biotech Exosome Rapid Molecular Detection Product Offered
11.8.3 Miltenyi Biotech Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Miltenyi Biotech Main Business Overview
11.8.5 Miltenyi Biotech Latest Developments
11.9 Norgen Biotek
11.9.1 Norgen Biotek Company Information
11.9.2 Norgen Biotek Exosome Rapid Molecular Detection Product Offered
11.9.3 Norgen Biotek Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Norgen Biotek Main Business Overview
11.9.5 Norgen Biotek Latest Developments
11.10 AMSBio
11.10.1 AMSBio Company Information
11.10.2 AMSBio Exosome Rapid Molecular Detection Product Offered
11.10.3 AMSBio Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AMSBio Main Business Overview
11.10.5 AMSBio Latest Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Information
11.11.2 Aethlon Medical Exosome Rapid Molecular Detection Product Offered
11.11.3 Aethlon Medical Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Aethlon Medical Main Business Overview
11.11.5 Aethlon Medical Latest Developments
11.12 Anjarium Biosciences
11.12.1 Anjarium Biosciences Company Information
11.12.2 Anjarium Biosciences Exosome Rapid Molecular Detection Product Offered
11.12.3 Anjarium Biosciences Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Anjarium Biosciences Main Business Overview
11.12.5 Anjarium Biosciences Latest Developments
11.13 Ciloa
11.13.1 Ciloa Company Information
11.13.2 Ciloa Exosome Rapid Molecular Detection Product Offered
11.13.3 Ciloa Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Ciloa Main Business Overview
11.13.5 Ciloa Latest Developments
11.14 InnovaPrep
11.14.1 InnovaPrep Company Information
11.14.2 InnovaPrep Exosome Rapid Molecular Detection Product Offered
11.14.3 InnovaPrep Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 InnovaPrep Main Business Overview
11.14.5 InnovaPrep Latest Developments
11.15 Creative Medical Technologies
11.15.1 Creative Medical Technologies Company Information
11.15.2 Creative Medical Technologies Exosome Rapid Molecular Detection Product Offered
11.15.3 Creative Medical Technologies Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Creative Medical Technologies Main Business Overview
11.15.5 Creative Medical Technologies Latest Developments
11.16 ILIAS Biologics
11.16.1 ILIAS Biologics Company Information
11.16.2 ILIAS Biologics Exosome Rapid Molecular Detection Product Offered
11.16.3 ILIAS Biologics Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 ILIAS Biologics Main Business Overview
11.16.5 ILIAS Biologics Latest Developments
11.17 Unchained Labs
11.17.1 Unchained Labs Company Information
11.17.2 Unchained Labs Exosome Rapid Molecular Detection Product Offered
11.17.3 Unchained Labs Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Unchained Labs Main Business Overview
11.17.5 Unchained Labs Latest Developments
11.18 Rion
11.18.1 Rion Company Information
11.18.2 Rion Exosome Rapid Molecular Detection Product Offered
11.18.3 Rion Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Rion Main Business Overview
11.18.5 Rion Latest Developments
11.19 Cell Guidance System
11.19.1 Cell Guidance System Company Information
11.19.2 Cell Guidance System Exosome Rapid Molecular Detection Product Offered
11.19.3 Cell Guidance System Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Cell Guidance System Main Business Overview
11.19.5 Cell Guidance System Latest Developments
11.20 INOVIQ
11.20.1 INOVIQ Company Information
11.20.2 INOVIQ Exosome Rapid Molecular Detection Product Offered
11.20.3 INOVIQ Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 INOVIQ Main Business Overview
11.20.5 INOVIQ Latest Developments
11.21 Danaher
11.21.1 Danaher Company Information
11.21.2 Danaher Exosome Rapid Molecular Detection Product Offered
11.21.3 Danaher Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Danaher Main Business Overview
11.21.5 Danaher Latest Developments
11.22 Exopharm
11.22.1 Exopharm Company Information
11.22.2 Exopharm Exosome Rapid Molecular Detection Product Offered
11.22.3 Exopharm Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Exopharm Main Business Overview
11.22.5 Exopharm Latest Developments
11.23 Everzom
11.23.1 Everzom Company Information
11.23.2 Everzom Exosome Rapid Molecular Detection Product Offered
11.23.3 Everzom Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Everzom Main Business Overview
11.23.5 Everzom Latest Developments
11.24 RoosterBio
11.24.1 RoosterBio Company Information
11.24.2 RoosterBio Exosome Rapid Molecular Detection Product Offered
11.24.3 RoosterBio Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 RoosterBio Main Business Overview
11.24.5 RoosterBio Latest Developments
11.25 Creative Biolabs
11.25.1 Creative Biolabs Company Information
11.25.2 Creative Biolabs Exosome Rapid Molecular Detection Product Offered
11.25.3 Creative Biolabs Exosome Rapid Molecular Detection Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Creative Biolabs Main Business Overview
11.25.5 Creative Biolabs Latest Developments
12 Research Findings and Conclusion
*If Applicable.
